AstraZeneca operates a significant research and development center in Maryland, conducting groundbreaking work in biomedicine and oncology. Sweden and the US have recently signed an agreement aimed at enhancing collaboration in cancer research, with a specific focus on prevention, control, screening, and management.
Maryland’s top export to Sweden was immunological products, put up in measured doses or in forms or packings for retail sale to a value of 59.7m USD. Maryland also exported 3m USD of articles of iron or steel.
